Skip to content
  • Tuesday, 30 June 2026
  • 5:20 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk’s Wegovy Pill Gains UK Approval Amidst Growing Demand and Competitive Landscape
Pharmaceutical R&D

Novo Nordisk’s Wegovy Pill Gains UK Approval Amidst Growing Demand and Competitive Landscape

Teuku Ryan Jun 14, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Novo Nordisk’s oral semaglutide medication, marketed…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce Competition

Teuku Ryan May 8, 2026 0

Novo Nordisk’s groundbreaking oral semaglutide medication, branded as Wegovy, has emerged as a powerful financial engine, propelling the Danish pharmaceutical…

Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo OutbreakCGTxchange Launches to Revitalize Shelved Cell and Gene Therapy ProgramsUniversity of Minnesota Researchers Discover New Method to Control Metal Electronic Properties Through Interfacial PolarizationGas streaming off comet 41P probably slowed it to a stop and began rotating it the other way
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ